Accumulating evidence from basic research shows that PCSK9 promotes vascular inflammation through upregulating classical pro-inflammatory pathways involved in atherosclerosis, such as TLR4/MyD88/NF-κB and NLRP3 inflammasomes [31,32]. Here, MYD88 is linked to atherosclerosis.